Boston Research & Management’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.76M Sell
46,797
-373
-0.8% -$56.5K 1.61% 23
2025
Q4
$6.76M Sell
47,170
-2,256
-5% -$333K 1.56% 23
2025
Q3
$7.59M Buy
49,426
+4,581
+10% +$715K 1.68% 19
2025
Q2
$7.14M Buy
44,845
+773
+2% +$126K 1.71% 20
2025
Q1
$7.51M Sell
44,072
-437
-1% -$73.2K 1.86% 17
2024
Q4
$7.46M Buy
44,509
+452
+1% +$77K 1.83% 16
2024
Q3
$7.63M Buy
44,057
+222
+0.5% +$37.7K 1.79% 19
2024
Q2
$7.23M Buy
43,835
+64
+0.1% +$10.5K 1.83% 14
2024
Q1
$7.1M Buy
43,771
+347
+0.8% +$54.4K 1.76% 18
2023
Q4
$6.36M Buy
43,424
+1,862
+4% +$276K 1.69% 20
2023
Q3
$6.06M Buy
41,562
+113
+0.3% +$17.3K 1.79% 17
2023
Q2
$6.29M Buy
41,449
+726
+2% +$109K 1.78% 19
2023
Q1
$6.05M Buy
40,723
+1,963
+5% +$281K 1.81% 18
2022
Q4
$5.87M Buy
38,760
+860
+2% +$121K 1.82% 17
2022
Q3
$4.78M Buy
37,900
+1,335
+4% +$190K 1.63% 20
2022
Q2
$5.26M Buy
36,565
+420
+1% +$63.1K 1.7% 19
2022
Q1
$5.52M Sell
36,145
-9,476
-21% -$1.48M 1.6% 19
2021
Q4
$7.46M Buy
45,621
+10
+0% +$1.49K 2.04% 14
2021
Q3
$6.38M Buy
45,611
+145
+0.3% +$20.6K 1.9% 14
2021
Q2
$6.13M Buy
45,466
+1,300
+3% +$176K 1.86% 18
2021
Q1
$5.98M Buy
44,166
+1,334
+3% +$174K 1.93% 16
2020
Q4
$5.96M Buy
42,832
+565
+1% +$79K 2.07% 14
2020
Q3
$5.87M Sell
42,267
-1,109
-3% -$147K 2.3% 9
2020
Q2
$5.19M Buy
43,376
+832
+2% +$97K 2.15% 14
2020
Q1
$4.68M Sell
42,544
-593
-1% -$71.2K 2.35% 11
2019
Q4
$5.39M Buy
43,137
+20
+0% +$2.45K 2.02% 11
2019
Q3
$5.36M Sell
43,117
-280
-0.6% -$33.1K 2.12% 10
2019
Q2
$4.76M Sell
43,397
-260
-0.6% -$27.7K 1.92% 16
2019
Q1
$4.54M Sell
43,657
-265
-0.6% -$25.8K 1.89% 17
2018
Q4
$4.04M Buy
43,922
+3,120
+8% +$279K 1.92% 21
2018
Q3
$3.4M Sell
40,802
-450
-1% -$36.8K 1.55% 31
2018
Q2
$3.22M Buy
41,252
+3,200
+8% +$241K 1.58% 30
2018
Q1
$3.02M Buy
38,052
+5,205
+16% +$434K 1.54% 32
2017
Q4
$3.02M Sell
32,847
-560
-2% -$50.4K 1.51% 36
2017
Q3
$3.04M Buy
33,407
+445
+1% +$40.5K 1.55% 35
2017
Q2
$2.87M Buy
32,962
+110
+0.3% +$9.7K 1.55% 36
2017
Q1
$2.95M Sell
32,852
-30
-0.1% -$2.66K 1.61% 31
2016
Q4
$2.76M Buy
32,882
+135
+0.4% +$11.5K 1.57% 30
2016
Q3
$2.94M Buy
32,747
+1,265
+4% +$110K 1.7% 25
2016
Q2
$2.67M Buy
31,482
+595
+2% +$48.8K 1.62% 31
2016
Q1
$2.54M Buy
30,887
+310
+1% +$25K 1.58% 31
2015
Q4
$2.43M Buy
30,577
+40
+0.1% +$3.06K 1.51% 31
2015
Q3
$2.2M Buy
30,537
+19,360
+173% +$1.45M 1.45% 30
2015
Q2
$874K Sell
11,177
-30
-0.3% -$2.41K 0.55% 60
2015
Q1
$918K Buy
11,207
+500
+5% +$43K 0.58% 59
2014
Q4
$975K Sell
10,707
-170
-2% -$15K 0.61% 59
2014
Q3
$910K Sell
10,877
-1,110
-9% -$91K 0.61% 60
2014
Q2
$942K Buy
11,987
+378
+3% +$30.5K 0.65% 58
2014
Q1
$935K Buy
11,609
+1,110
+11% +$87.5K 0.69% 56
2013
Q4
$854K Sell
10,499
-400
-4% -$32.6K 0.66% 57
2013
Q3
$823K Hold
10,899
0.7% 55
2013
Q2
$839K Buy
+10,899
New +$855K 0.75% 53

Other funds holding PG

Boston Research & Management's PG Position: Q1 2026 in Review

Boston Research & Management reduced its Procter & Gamble (PG) stake by 0.79% in Q1 2026, selling an estimated $56.5K and leaving 46,797 shares worth $6.76M. The position accounts for 1.61% of the portfolio, ranked #23.

Boston Research & Management first reported a position in PG in Q2 2013 and has held it in 52 quarters since. The position peaked at $7.63M in Q3 2024. 3,984 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Boston Research & Management held 46,797 shares of Procter & Gamble worth $6.76M as of Q1 2026.
  • Boston Research & Management sold 373 Procter & Gamble shares in Q1 2026, an estimated $56.5K.
  • Procter & Gamble made up 1.61% of Boston Research & Management's portfolio in Q1 2026, its #23 holding.
  • Boston Research & Management first reported a position in Procter & Gamble in Q2 2013 and has held it in 52 quarters since.
  • Boston Research & Management's Procter & Gamble position peaked at $7.63M in Q3 2024.
  • 3,984 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Boston Research & Management's 13F filing for Q1 2026, filed 10 Apr 2026.